Intermedin protects against ischaemia-reperfusion injury in human ventricular cardiomyocytes: receptor subtype involvement: European Heart Journal 34 Suppl 1

Stephen McAleer; Mark Harbinson; Malcolm Campbell; Matthew  Ferguson; David Bell

Intermedin protects against ischaemia-reperfusion injury in human ventricular cardiomyocytes: receptor subtype involvement: European Heart Journal 34 Suppl 1

Stephen McAleer, Mark Harbinson, Malcolm Campbell, Matthew Ferguson, David Bell

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	1022
Number of pages	1
Publication status	Published - 01 Aug 2013
Event	European Society of Cardiology - Amsterdam, Netherlands Duration: 31 Aug 2013 → 04 Sept 2013

Conference

Conference	European Society of Cardiology
Country/Territory	Netherlands
City	Amsterdam
Period	31/08/2013 → 04/09/2013

Cite this

@conference{52b959d124d74f18a9dec9f6a3090592,

title = "Intermedin protects against ischaemia-reperfusion injury in human ventricular cardiomyocytes: receptor subtype involvement: European Heart Journal 34 Suppl 1",

author = "Stephen McAleer and Mark Harbinson and Malcolm Campbell and Matthew Ferguson and David Bell",

year = "2013",

month = aug,

day = "1",

language = "English",

pages = "1022",

note = "European Society of Cardiology ; Conference date: 31-08-2013 Through 04-09-2013",

}

Intermedin protects against ischaemia-reperfusion injury in human ventricular cardiomyocytes: receptor subtype involvement: European Heart Journal 34 Suppl 1. / McAleer, Stephen; Harbinson, Mark; Campbell, Malcolm et al.
2013. 1022 Abstract from European Society of Cardiology, Amsterdam, Netherlands.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Intermedin protects against ischaemia-reperfusion injury in human ventricular cardiomyocytes: receptor subtype involvement

T2 - European Society of Cardiology

AU - McAleer, Stephen

AU - Harbinson, Mark

AU - Campbell, Malcolm

AU - Ferguson, Matthew

AU - Bell, David

PY - 2013/8/1

Y1 - 2013/8/1

M3 - Abstract

SP - 1022

Y2 - 31 August 2013 through 4 September 2013

ER -